REVERSE TRANSLATIONAL MEDICINE
Neurimmune Holding AG
>Mark For: REVERSE TRANSLATIONAL MEDICINE® trademark registration is intended to cover the following codes and category IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; diagnostic preparations for medical and veterinary use; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseasesIC 042. US 100 101. G & S: Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer hardware design and development; computer software design and developmentIC 044. US 100 101. G & S: Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
>Color is not claimed as a feature of the mark.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85984179 |
| Registration Number | 5188931 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Domestic Representative | Janice Housey |
| Attorney Name | Janice Housey |
| Law Office Assigned | M20 |
| Employee Name | LEHKER, DAWN FELDMAN |
Timeline
| 2012-06-20 | Application Filed |
| 2016-11-01 | Published for Opposition |
| 2017-04-25 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-04-25 | Status: Live/Registered |
| 2017-04-25 | Trademark Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Neurimmune Holding AG |
| Entity Statement | aktiengesellschaft |
| Address | Wagistrasse 13 Schlieren CH 8952 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
 Application | APPLICATION/XML,IMAGE/JPEG | 2012-06-20 |
 Drawing | IMAGE/JPEG | 2012-06-20 |
| Offc Action Outgoing | APPLICATION/XML,IMAGE/JPEG | 2012-10-16 |
| XSearch Search Summary | APPLICATION/XML | 2012-10-16 |
| Response to Office Action | APPLICATION/XML | 2013-02-13 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2013-02-15 |
| Notation to File | APPLICATION/XML | 2013-03-22 |
| Offc Action Outgoing | APPLICATION/XML | 2013-03-22 |
| Response to Office Action | APPLICATION/XML | 2013-09-16 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2013-09-17 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2013-09-18 |
| Examiners Amendment | APPLICATION/XML | 2013-10-07 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2013-10-08 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2013-10-08 |
| Publication & Issue Review Complete | APPLICATION/XML,IMAGE/JPEG | 2013-10-11 |
| Offc Action Outgoing | APPLICATION/XML | 2013-11-04 |
| Examiners Amendment | APPLICATION/XML | 2014-02-05 |
| Amendment and Mail Process Complete | APPLICATION/XML,IMAGE/JPEG | 2014-02-06 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2014-02-06 |
| Publication & Issue Review Complete | APPLICATION/XML,IMAGE/JPEG | 2014-02-07 |
| Notice of Publication | APPLICATION/XML | 2014-02-19 |
| Notification Of Notice of Publication | APPLICATION/XML | 2014-02-19 |
| OG Publication Confirmation | APPLICATION/XML | 2014-03-11 |
| Notice of Allowance | APPLICATION/XML | 2014-05-06 |
| Extension of Time to File SOU | APPLICATION/XML | 2014-06-13 |
| ITU Extension Approval | APPLICATION/XML | 2014-06-17 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2014-06-17 |
| Extension of Time to File SOU | APPLICATION/XML,IMAGE/TIFF | 2015-04-15 |
| ITU Extension Approval | APPLICATION/XML | 2015-05-19 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2015-05-19 |
| Extension of Time to File SOU | APPLICATION/XML,IMAGE/TIFF | 2015-10-07 |
| ITU Extension Approval | APPLICATION/XML | 2015-10-16 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2015-10-16 |
| Change of Address | APPLICATION/XML | 2016-03-10 |
| Extension of Time to File SOU | APPLICATION/XML,IMAGE/TIFF | 2016-04-21 |
| ITU Extension Approval | APPLICATION/XML | 2016-04-23 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2016-04-23 |
| Request to Divide | APPLICATION/XML,IMAGE/JPEG | 2016-04-26 |
| Offc Action Outgoing | APPLICATION/XML | 2016-06-10 |
| Prosecution History for Informal Notice | APPLICATION/XML,IMAGE/JPEG | 2016-06-11 |
| Petition to Amend Basis Post-publication | APPLICATION/XML,IMAGE/JPEG | 2016-06-22 |
| Offc Action Outgoing | APPLICATION/XML | 2016-07-13 |
| Petition to Director Granted | APPLICATION/XML | 2016-08-04 |
| Amendment to Delete or Correct Basis | APPLICATION/XML,IMAGE/JPEG | 2016-09-29 |
| ITU Unit Action | APPLICATION/XML,IMAGE/JPEG | 2016-09-29 |
| Notice of Publication | APPLICATION/XML | 2016-10-12 |
| Notification Of Notice of Publication | APPLICATION/XML | 2016-10-12 |
| OG Publication Confirmation | APPLICATION/XML | 2016-11-01 |
| Registration Certificate | APPLICATION/PDF | 2017-04-25 |
| Change Address or Representation Form | APPLICATION/XML | 2021-07-21 |
| Change Address or Representation Form | APPLICATION/XML | 2022-01-21 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations to treat diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases; synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; biological preparations for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; diagnostic preparations for medical and veterinary use; Dietetic food, namely, gluten-free food, low-sodium food, low-calorie or reduced calorie food for weight reduction adapted for medical purposes, namely, dietetic bread and dietetic noodles; dietetic beverages, namely, gluten-free beverages, low-sodium beverages, namely, dietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposes, namely, low calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases
IC 042. US 100 101. G & S: Testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; Consultation and providing information about testing, inspection or research of pharmaceuticals, cosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testing, inspection or research of medical treatment and technique; scientific research about health care; biology research; computer hardware design and development; computer software design and development
IC 044. US 100 101. G & S: Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2012-06-23 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2012-06-28 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2012-10-05 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2012-10-16 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2012-10-16 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2012-10-16 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2013-02-13 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2013-02-13 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2013-02-14 | 9 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2013-03-22 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2013-03-22 | 11 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2013-03-22 | 12 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2013-09-16 | 13 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2013-09-16 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2013-09-16 | 15 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-09-17 | 16 CNSA P: |
| ASSIGNED TO LIE | 2013-09-28 | 17 ALIE A:Allowance for Publication |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2013-10-07 | 18 ZZZX Z:Deletion |
| EXAMINERS AMENDMENT -WRITTEN | 2013-10-07 | 19 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2013-10-07 | 20 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2013-10-07 | 21 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2013-10-07 | 22 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2013-10-07 | 23 CNSA P: |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2013-10-10 | 24 PREV O:Outgoing Correspondence |
| WITHDRAWN FROM PUB - OG REVIEW QUERY | 2013-10-20 | 25 PBCR Z:Deletion |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2013-10-25 | 26 ZZZX Z:Deletion |
| NON-FINAL ACTION WRITTEN | 2013-11-04 | 27 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2013-11-04 | 28 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2013-11-04 | 29 GNRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2014-02-05 | 30 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2014-02-05 | 31 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2014-02-05 | 32 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2014-02-05 | 33 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-02-05 | 34 CNSA P: |
| ASSIGNED TO LIE | 2014-02-05 | 35 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2014-02-06 | 36 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2014-02-19 | 37 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2014-03-11 | 38 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2014-03-11 | 39 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2014-05-06 | 40 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2014-06-13 | 41 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2014-06-13 | 42 EXT1 S: |
| EXTENSION 1 GRANTED | 2014-06-13 | 43 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2014-06-17 | 44 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2015-04-15 | 45 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2015-05-16 | 46 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2015-04-15 | 47 EXT2 S: |
| EXTENSION 2 GRANTED | 2015-05-16 | 48 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-05-19 | 49 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2015-10-07 | 50 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2015-10-14 | 51 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2015-10-07 | 52 EXT3 S: |
| EXTENSION 3 GRANTED | 2015-10-15 | 53 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-10-16 | 54 EXRA E:E-Mail |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2016-03-10 | 55 TCCA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2016-04-21 | 56 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2016-04-21 | 57 EXT4 S: |
| EXTENSION 4 GRANTED | 2016-04-22 | 58 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-04-23 | 59 EXRA E:E-Mail |
| TEAS REQUEST TO DIVIDE RECEIVED | 2016-04-26 | 60 ERTD I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-06-07 | 61 AITU A:Allowance for Publication |
| REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN | 2016-06-10 | 62 UNTD O:Outgoing Correspondence |
| TEAS PETITION TO AMEND BASIS RECEIVED | 2016-06-22 | 63 TPAD I:Incoming Correspondence |
| ASSIGNED TO PETITION STAFF | 2016-07-08 | 64 APET A:Allowance for Publication |
| DIVISIONAL REQUEST RECEIVED | 2016-06-22 | 65 DRRR I:Incoming Correspondence |
| DIVISIONAL PROCESSING COMPLETE | 2016-07-13 | 66 DPCC D:Assigned to Examiner |
| PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | 2016-08-04 | 67 PCBG O:Outgoing Correspondence |
| ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED | 2016-08-04 | 68 ATRQ I:Incoming Correspondence |
| NOTICE OF ALLOWANCE CANCELLED | 2016-09-28 | 69 IUCN S: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-10-12 | 70 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2016-11-01 | 71 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-11-01 | 72 NPUB E:E-Mail |
| EXTENSION OF TIME TO OPPOSE RECEIVED | 2016-12-01 | 73 ETOF T:TTAB Proceeding |
| EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2017-03-17 | 74 ETOP T:TTAB Proceeding |
| REGISTERED-PRINCIPAL REGISTER | 2017-04-25 | 75 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-07-21 | 76 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-07-21 | 77 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-07-21 | 78 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-07-21 | 79 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-01-21 | 80 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-01-21 | 81 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-01-21 | 82 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-01-21 | 83 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-01-21 | 84 CHAN I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-04-25 | 85 REM1 E:E-Mail |
| TEAS SECTION 8 & 15 RECEIVED | 2022-12-15 | 86 E815 I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-06-15 | 87 APRE A:Allowance for Publication |
| REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-06-15 | 88 C15P O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-06-15 | 89 NA85 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-11-10 | 90 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-11-10 | 91 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-11-10 | 92 TCCA I:Incoming Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 